The Precision Medicine Innovation Co-Laboratory—or PMedIC—is a joint research collaboration of the Oregon Health & Science University and the U.S. Department of Energy's Pacific Northwest National Laboratory.
Our mission: Generate, interpret, and apply multidimensional patient data such as genetic, proteomic, and metabolic profiles, and integrate this information with imaging and clinical results, to customize disease treatment and improve human health.
Our vision: Transform precision medicine, strengthen the regional workforce, and attract top scientific talent to the Northwest.
OHSU and PNNL launched PMedIC on February 14, 2018 at OHSU in Portland, Oregon. See the news release and program, and photos. Media coverage from the launch: Portland Business Journal and Oregon Public Broadcasting.
To be notified of PMedIC updates: Request to be added to the mailing list.
PMedIC offers researchers access to some of the world’s most advanced analytical instrumentation, as well as the opportunity to collaborate with nationally recognized experts in 'omics and related fields.
PMedIC combines the passion, resources, and expertise of OHSU and PNNL to advance the science and practice of precision medicine. New insights from PMedIC's approach will lead to more customized treatments and better patient outcomes.
For additional information on the Precision Medicine Innovation
Co-Laboratory (PMedIC), please email PMedIC.
Mailing address:
OHSU School of Medicine
3131 SW Sam Jackson Parkway, L102
Portland, OR 97239